{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "antitumor", "cell lines", "modifications", "synthesis", "ursolic acid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36558113", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "26"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["8981", "10.3390/molecules27248981"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "24", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "16"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Ursolic Acid Analogs as Potential Therapeutics for Cancer.", "Abstract": {"AbstractText": ["Ursolic acid (UA) is a pentacyclic triterpene isolated from a large variety of vegetables, fruits and many traditional medicinal plants. It is a structural isomer of Oleanolic Acid. The medicinal application of UA has been explored extensively over the last two decades. The diverse pharmacological properties of UA include anti-inflammatory, antimicrobial, antiviral, antioxidant, anti-proliferative, etc. Especially, UA holds a promising position, potentially, as a cancer preventive and therapeutic agent due to its relatively non-toxic properties against normal cells but its antioxidant and antiproliferative activities against cancer cells. Cell culture studies have shown interference of UA with multiple pharmacological and molecular targets that play a critical role in many cells signaling pathways. Although UA is considered a privileged natural product, its clinical applications are limited due to its low absorption through the gastro-intestinal track and rapid elimination. The low bioavailability of UA limits its use as a therapeutic drug. To overcome these drawbacks and utilize the importance of the scaffold, many researchers have been engaged in designing and developing synthetic analogs of UA via structural modifications. This present review summarizes the synthetic UA analogs and their cytotoxic antiproliferative properties reported in the last two decades."]}, "AuthorList": [{"Identifier": ["0000-0003-3668-104X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Physics, Augusta University, Augusta, GA 30912, USA."}], "LastName": "Panda", "ForeName": "Siva S", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA 30912, USA."}, {"Identifier": [], "Affiliation": "Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA."}], "LastName": "Thangaraju", "ForeName": "Muthusamy", "Initials": "M"}, {"Identifier": ["0000-0002-1763-4718"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA 30912, USA."}, {"Identifier": [], "Affiliation": "Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA."}, {"Identifier": [], "Affiliation": "Research Service, Charlie Norwood Veterans Administration Medical Center, Augusta, GA 30912, USA."}], "LastName": "Lokeshwar", "ForeName": "Bal L", "Initials": "BL"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology", "therapeutic use", "chemistry"], "DescriptorName": "Triterpenes"}, {"QualifierName": [], "DescriptorName": "Ursolic Acid"}], "CoiStatement": "The authors declare no conflict of interest"}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2022. CA A Cancer J. Clin. 2022;72:7\u201333. doi: 10.3322/caac.21708.", "ArticleIdList": ["10.3322/caac.21708", "35020204"]}, {"Citation": "Yabroff K.R., Mariotto A.M., Tangka F., Zhao J., Islami F., Sung H., Sherman R.L., Henley S.J., Jemal A., Ward E.M. Annual Report to the Nation on the Status of Cancer, Part II: Patient Economic Burden Associated with Cancer Care. J. Natl. Cancer Inst. 2021;113:1670\u20131682. doi: 10.1093/jnci/djab192.", "ArticleIdList": ["10.1093/jnci/djab192", "34698839"]}, {"Citation": "Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (review) Int. J. Oncol. 2019;54:407\u2013419.", "ArticleIdList": ["PMC6317661", "30570109"]}, {"Citation": "Pejin B., Jovanovi K.K., Mojovi M., Savi A.G. New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012. Curr. Top. Med. Chem. 2013;13:2745\u20132766. doi: 10.2174/15680266113136660197.", "ArticleIdList": ["10.2174/15680266113136660197", "24083789"]}, {"Citation": "Sisodiya P.S. Plant Derived Anticancer Agents: A Review. Int. J. Res. Dev. Pharm. Life Sci. 2013;2:293\u2013308."}, {"Citation": "Pejin B., Glumac M.A. brief review of potent anti-CNS tumourics from marine sponges: Covering the period from 1994 to 2014. Nat. Prod. Res. 2018;32:375\u2013384. doi: 10.1080/14786419.2017.1309400.", "ArticleIdList": ["10.1080/14786419.2017.1309400", "28385035"]}, {"Citation": "Calcabrini C., Catanzaro E., Bishayee A., Turrini E., Fimognari C. Marine Sponge Natural Products with Anticancer Potential: An Updated Review. Mar. Drugs. 2017;15:310. doi: 10.3390/md15100310.", "ArticleIdList": ["10.3390/md15100310", "PMC5666418", "29027954"]}, {"Citation": "Cragg G.M., Pezzuto J.M. Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents. Med. Princ. Pract. 2016;25:41\u201359. doi: 10.1159/000443404.", "ArticleIdList": ["10.1159/000443404", "PMC5588531", "26679767"]}, {"Citation": "Demain A.L., Vaishnav P. Natural products for cancer chemotherapy. Microb. Biotechnol. 2011;4:687\u2013699. doi: 10.1111/j.1751-7915.2010.00221.x.", "ArticleIdList": ["10.1111/j.1751-7915.2010.00221.x", "PMC3815406", "21375717"]}, {"Citation": "Rajesh E., Sankari L.S., Malathi L., Krupaa J.R. Naturally occurring products in cancer therapy. J. Pharm. Bioallied Sci. 2015;7:S181\u2013S183. doi: 10.4103/0975-7406.155895.", "ArticleIdList": ["10.4103/0975-7406.155895", "PMC4439664", "26015704"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Katz L., Baltz R.H. Natural product discovery: Past, present, and future. J. Ind. Microbiol. Biotechnol. 2016;43:155\u2013176. doi: 10.1007/s10295-015-1723-5.", "ArticleIdList": ["10.1007/s10295-015-1723-5", "26739136"]}, {"Citation": "Liby K.T., Yore M.M., Sporn M.B. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer. 2007;7:357\u2013369. doi: 10.1038/nrc2129.", "ArticleIdList": ["10.1038/nrc2129", "17446857"]}, {"Citation": "Bishayee A., Ahmed S., Brankov N., Perloff M. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front. Biosci. 2011;16:980\u2013996. doi: 10.2741/3730.", "ArticleIdList": ["10.2741/3730", "PMC3057757", "21196213"]}, {"Citation": "Aksit H., Gozcu S., Altay A. Isolation and cytotoxic activities of undescribed iridoid and xanthone glycosides from Centaurium erythraea Rafn. (Gentianaceae) Phytochemistry. 2023;205:113484. doi: 10.1016/j.phytochem.2022.113484.", "ArticleIdList": ["10.1016/j.phytochem.2022.113484", "36309110"]}, {"Citation": "Mlala S., Oyedeji A.O., Gondwe M., Oyedeji O.O. Ursolic Acid and Its Derivatives as Bioactive Agents. Molecules. 2019;24:2751. doi: 10.3390/molecules24152751.", "ArticleIdList": ["10.3390/molecules24152751", "PMC6695944", "31362424"]}, {"Citation": "Seo D.Y., Lee S.R., Heo J.-W., No M.-H., Rhee B.D., Ko K.S., Kwak H.-B., Han J. Ursolic acid in health and disease. Korean J. Physiol. Pharmacol. 2018;22:235\u2013248. doi: 10.4196/kjpp.2018.22.3.235.", "ArticleIdList": ["10.4196/kjpp.2018.22.3.235", "PMC5928337", "29719446"]}, {"Citation": "Lopez-Hortas L., Perez-Larran P., Gonzalez-Munoz M.J., Falque E., Dominguez H. Recent developments on the extraction and application of ursolic acid. A review. Food Res. Int. 2018;103:130\u2013149. doi: 10.1016/j.foodres.2017.10.028.", "ArticleIdList": ["10.1016/j.foodres.2017.10.028", "29389599"]}, {"Citation": "Li C., Chen W., Zheng L., Zhang B., Yang X., Zhang Q., Wang N., Wang Y., Yang J., Sha J. Ameliorative effect of ursolic acid on ochratoxin A-induced renal cytotoxicity mediated by Lonp1/Aco2/Hsp75. Toxicon. 2019;168:141\u2013146. doi: 10.1016/j.toxicon.2019.07.014.", "ArticleIdList": ["10.1016/j.toxicon.2019.07.014", "31356822"]}, {"Citation": "Ozdemir Z., Wimmer Z. Selected plant triterpenoids and their amide derivatives in cancer treatment: A review. Phytochemistry. 2022;203:113340. doi: 10.1016/j.phytochem.2022.113340.", "ArticleIdList": ["10.1016/j.phytochem.2022.113340", "35987401"]}, {"Citation": "Kornel A., Nadile M., Tsiani E. Evidence of the Beneficial Effects of Ursolic Acid against Lung Cancer. Molecules. 2022;27:7466. doi: 10.3390/molecules27217466.", "ArticleIdList": ["10.3390/molecules27217466", "PMC9655894", "36364289"]}, {"Citation": "Wang L., Yin Q., Liu C., Tang Y., Sun C., Zhuang J. Nanoformulations of ursolic acid: A modern natural anticancer molecule. Front. Pharmacol. 2021;12:706121. doi: 10.3389/fphar.2021.706121.", "ArticleIdList": ["10.3389/fphar.2021.706121", "PMC8289884", "34295253"]}, {"Citation": "Sycz Z., Tichaczek-Goska D., Wojnicz D. Anti-Planktonic and Anti-Biofilm Properties of Pentacyclic Triterpenes-Asiatic Acid and Ursolic Acid as Promising Antibacterial Future Pharmaceuticals. Biomolecules. 2022;12:98. doi: 10.3390/biom12010098.", "ArticleIdList": ["10.3390/biom12010098", "PMC8774094", "35053246"]}, {"Citation": "Jesus J.A., Lago J.H.G., Laurenti M.D., Yamamoto E.S., Passero L.F.D. Antimicrobial activity of oleanolic and ursolic acids: An update. Evid. Based Complement. Altern. Med. 2015;2015:620472. doi: 10.1155/2015/620472.", "ArticleIdList": ["10.1155/2015/620472", "PMC4352472", "25793002"]}, {"Citation": "Al-kuraishy H.M., Al-Gareeb A.I., Negm W.A., Alexiou A., Batiha G.E.S. Ursolic acid and SARS-CoV-2 infection: A new horizon and perspective. Inflammopharmacology. 2022;30:1493\u20131501. doi: 10.1007/s10787-022-01038-3.", "ArticleIdList": ["10.1007/s10787-022-01038-3", "PMC9362167", "35922738"]}, {"Citation": "Bachar S.C., Mazumder K., Bachar R., Aktar A., Al Mahtab M. A review of medicinal plants with antiviral activity available in Bangladesh and mechanistic insight into their bioactive metabolites on SARS-CoV-2, HIV and HBV. Front. Pharmacol. 2021;12:732891. doi: 10.3389/fphar.2021.732891.", "ArticleIdList": ["10.3389/fphar.2021.732891", "PMC8606584", "34819855"]}, {"Citation": "Gudoityte E., Arandarcikaite O., Mazeikiene I., Bendokas V., Liobikas J. Ursolic and oleanolic acids: Plant metabolites with neuroprotective potential. Int. J. Mol. Sci. 2021;22:4599. doi: 10.3390/ijms22094599.", "ArticleIdList": ["10.3390/ijms22094599", "PMC8124962", "33925641"]}, {"Citation": "Li W., Sun K., Hu F., Chen L., Zhang X., Wang F., Yan B. Protective effects of natural compounds against oxidative stress in ischemic diseases and cancers via activating the Nrf2 signaling pathway: A mini review. J. Biochem. Mol. Toxicol. 2021;35:e22658. doi: 10.1002/jbt.22658.", "ArticleIdList": ["10.1002/jbt.22658", "33118292"]}, {"Citation": "Habtemariam S. Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: Addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression. Oxid. Med. Cell. Longev. 2019;2019:8512048. doi: 10.1155/2019/8512048.", "ArticleIdList": ["10.1155/2019/8512048", "PMC6541953", "31223427"]}, {"Citation": "Kashyap D., Sharma A., Tuli H.S., Punia S., Sharma A.K. Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities. Recent Pat. Inflamm. Allergy Drug Discov. 2016;10:21\u201333. doi: 10.2174/1872213X10666160711143904.", "ArticleIdList": ["10.2174/1872213X10666160711143904", "27531153"]}, {"Citation": "Luan M., Wang H., Wang J., Zhang X., Zhao F., Liu Z., Meng Q. Advances in anti-inflammatory activity, mechanism and therapeutic application of ursolic acid. Mini-Revi. Med. Chem. 2022;22:423\u2013437.", "ArticleIdList": ["34517797"]}, {"Citation": "Achiwa Y., Hasegawa K., Udagawa Y., Achiwa Y., Hasegawa K., Udagawa Y. Effect of ursolic acid on MAPK in cyclin D1 signaling and RING-type E3 ligase (SCF E3s) in two endometrial cancer cell lines. Nutr. Cancer. 2013;65:1026\u20131033. doi: 10.1080/01635581.2013.810292.", "ArticleIdList": ["10.1080/01635581.2013.810292", "24083669"]}, {"Citation": "Prasad S., Yadav V.R., Sung B., Gupta S.C., Tyagi A.K. Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment. Oncotarget. 2016;7:13182. doi: 10.18632/oncotarget.7537.", "ArticleIdList": ["10.18632/oncotarget.7537", "PMC4914350", "26909608"]}, {"Citation": "Huang C.Y., Lin C.Y., Tsai C.W., Yin M.C. Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol. Vitr. 2011;25:1274\u20131280. doi: 10.1016/j.tiv.2011.04.014.", "ArticleIdList": ["10.1016/j.tiv.2011.04.014", "21539908"]}, {"Citation": "Kim S., Ryu H.G., Lee J., Shin J., Harikishore A., Jung H.Y., Kim Y.S., Lyu H.N., Oh E., Baek N.I., et al. Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells. Sci. Rep. 2015;5:14570. doi: 10.1038/srep14570.", "ArticleIdList": ["10.1038/srep14570", "PMC4585938", "26412148"]}, {"Citation": "Kassi E., Papoutsi Z., Pratsinis H., Aligiannis N., Manoussakis M., Moutsatsou P. Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells. J. Cancer Res. Clin. Oncol. 2007;133:493\u2013500. doi: 10.1007/s00432-007-0193-1.", "ArticleIdList": ["10.1007/s00432-007-0193-1", "17516089"]}, {"Citation": "Shanmugam M.K., Rajendran P., Li F., Nema T., Vali S., Abbasi T., Kapoor S., Sharma A., Kumar A.P., Ho P.C., et al. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J. Mol. Med. 2011;89:713\u2013727. doi: 10.1007/s00109-011-0746-2.", "ArticleIdList": ["10.1007/s00109-011-0746-2", "21465181"]}, {"Citation": "Gai W.T., Yu D.P., Wang X.S., Wang P.T. Anti-cancer e_ect of ursolic acid activates apoptosis through ROCK/PTEN mediated mitochondrial translocation of cofilin-1 in prostate cancer. Oncol. Lett. 2016;12:2880\u20132885. doi: 10.3892/ol.2016.5015.", "ArticleIdList": ["10.3892/ol.2016.5015", "PMC5038386", "27698874"]}, {"Citation": "Yang L., Liu X., Lu Z., Yuet W.J., Zhou L.L., Fung K.P., Wu P., Wu S. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor. Cancer Lett. 2010;298:128\u2013138. doi: 10.1016/j.canlet.2010.06.010.", "ArticleIdList": ["10.1016/j.canlet.2010.06.010", "20630652"]}, {"Citation": "Zheng Q., Li P., Jin F., Yao C., Zhang G., Zang T., Ai X. Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells. Cell. Signal. 2013;25:206\u2013213. doi: 10.1016/j.cellsig.2012.09.012.", "ArticleIdList": ["10.1016/j.cellsig.2012.09.012", "23000344"]}, {"Citation": "Xu X., Zhu G., Zhang K., Zhou Y., Li X., Xu W., Zhang H., Shao Y., Zhang Z., Sun W. Cyclooxygenase-2 mediated synergistic effect of ursolic acid in combination with paclitaxel against human gastric carcinoma. Oncotarget. 2017;8:92770\u201392777. doi: 10.18632/oncotarget.21576.", "ArticleIdList": ["10.18632/oncotarget.21576", "PMC5696220", "29190954"]}, {"Citation": "Kim E.S., Moon A. Ursolic acid inhibits the invasive phenotype of SNU-484 human gastric cancer cells. Oncol. Lett. 2015;9:897\u2013902. doi: 10.3892/ol.2014.2735.", "ArticleIdList": ["10.3892/ol.2014.2735", "PMC4301486", "25621065"]}, {"Citation": "Prasad S., Yadav V.R., Kannappan R., Aggarwal B.B. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors. J. Biol. Chem. 2016;291:16924. doi: 10.1074/jbc.A110.183699.", "ArticleIdList": ["10.1074/jbc.A110.183699", "PMC4974407", "27496965"]}, {"Citation": "Wang C., Lin C., Hua C., Jou Y., Liao C., Chang Y., Wan L., Huang S., Hour M., Lin C. Cis-3-O-p-hydroxycinnamoyl ursolic acid induced ROS-dependent p53-mediated mitochondrial apoptosis in oral cancer cells. Biomol. Ther. 2019;27:54\u201362. doi: 10.4062/biomolther.2017.237.", "ArticleIdList": ["10.4062/biomolther.2017.237", "PMC6319548", "30261716"]}, {"Citation": "Jiang K., Chi T., Li T., Zheng G., Fan L., Liu Y., Chen X., Chen S., Jia L., Shao J. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: Suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways. Nanoscale. 2017;9:9428\u20139439. doi: 10.1039/C7NR01677H.", "ArticleIdList": ["10.1039/C7NR01677H", "28660943"]}, {"Citation": "Kim J., Kim Y.H., Song G., Kim D., Jeong Y., Liu K., Chung Y., Oh S. Ursolic acid and its natural derivative corosolic acid suppress the proliferation of APC-mutated colon cancer cells through promotion of \u03b2-catenin degradation. Food Chem. Toxicol. 2014;67:87\u201395. doi: 10.1016/j.fct.2014.02.019.", "ArticleIdList": ["10.1016/j.fct.2014.02.019", "24566423"]}, {"Citation": "Zhang R., Li Y., Tian D., Liu Y., Nian W., Zou X., Chen Q., Zhou L., Deng Z., He B. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/\u03b2-catenin signaling in human osteosarcoma cells. Int. J. Oncol. 2016;49:1973\u20131982. doi: 10.3892/ijo.2016.3701.", "ArticleIdList": ["10.3892/ijo.2016.3701", "27665868"]}, {"Citation": "Kim S., Jin H., Meng R.Y., Kim D.Y., Liu Y.C., Chai O.H., Park B.H., Kim S. Activating hippo pathway via Rassf1 by ursolic acid suppresses the tumorigenesis of gastric cancer. Int. J. Mol. Sci. 2019;20:4709. doi: 10.3390/ijms20194709.", "ArticleIdList": ["10.3390/ijms20194709", "PMC6801984", "31547587"]}, {"Citation": "Choi W., Hyung. Lee, I A. The mechanism of action of ursolic acid as a potential anti-toxoplasmosis agent, and its immunomodulatory effects. Pathogens. 2019;8:61. doi: 10.3390/pathogens8020061.", "ArticleIdList": ["10.3390/pathogens8020061", "PMC6631288", "31075881"]}, {"Citation": "Pathak A.K., Bhutani M., Nair A.S., Kwang S.A., Chakraborty A., Kadara H., Guha S., Sethi G., Aggarwal B.B. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol. Cancer Res. 2007;5:943\u2013955. doi: 10.1158/1541-7786.MCR-06-0348.", "ArticleIdList": ["10.1158/1541-7786.MCR-06-0348", "17855663"]}, {"Citation": "Wang W., Zhao C., Jou D., L\u00fc J., Zhang C., Lin L., Lin J. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3. Anticancer Res. 2013;33:4279\u20134284.", "ArticleIdList": ["24122993"]}, {"Citation": "Liu T., Ma H., Shi W., Duan J., Wang Y., Zhang C., Li C., Lin J., Li S., Lv J., et al. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma. Int. J. Oncol. 2017;51:555\u2013562. doi: 10.3892/ijo.2017.4035.", "ArticleIdList": ["10.3892/ijo.2017.4035", "28714512"]}, {"Citation": "Xia Y., Wei G., Si D., Liu C. Quantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011;879:219\u2013224. doi: 10.1016/j.jchromb.2010.11.037.", "ArticleIdList": ["10.1016/j.jchromb.2010.11.037", "21169069"]}, {"Citation": "Shanmugam N.K.N., Ong T.H., Kumar A.P., Lun C.K., Ho P.C., Wong P.T.H., Hui K.M., Sethi G. Ursolic Acid Inhibits the Initiation, Progression of Prostate Cancer and Prolongs the Survival of TRAMP Mice by Modulating Pro-Inflammatory Pathways. PLoS ONE. 2012;7:e32476. doi: 10.1371/journal.pone.0032476.", "ArticleIdList": ["10.1371/journal.pone.0032476", "PMC3299664", "22427843"]}, {"Citation": "Zhu Z., Qian Z., Yan Z., Zhao C., Wang H., Ying G. A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors. Int. J. Nanomed. 2012;8:129\u2013136.", "ArticleIdList": ["PMC3540956", "23319864"]}, {"Citation": "Bahia S.B.B., Reis W.J., Jardim G.A., Souto F.T., de Simone C.A., Gatto C.C., Menna-Barreto R.F., de Castro S.L., Cavalcanti B.C., Pessoa C., et al. Molecular hybridization as a powerful tool towards multitarget quinoidal systems: Synthesis, trypanocidal and antitumor activities of naphthoquinone-based 5-iodo-1,4-disubstituted-, 1,4- and 1,5-disubstituted-1,2,3-triazoles. MedChemComm. 2016;7:1555\u20131563. doi: 10.1039/C6MD00216A.", "ArticleIdList": ["10.1039/C6MD00216A"]}, {"Citation": "Bosquesi P.L., Melo T.R.F., Vizioli E.O., dos Santos J.L., Chung M.C. Anti-inflammatory drug design using a molecular hybridization approach. Pharmaceuticals. 2011;4:1450\u20131474. doi: 10.3390/ph4111450.", "ArticleIdList": ["10.3390/ph4111450", "PMC4060134", "27721332"]}, {"Citation": "Fershtat L.L., Makhova N.N. Molecular Hybridization Tools in the Development of Furoxan-Based NO-Donor Prodrugs. ChemMedChem. 2017;12:622\u2013638. doi: 10.1002/cmdc.201700113.", "ArticleIdList": ["10.1002/cmdc.201700113", "28371340"]}, {"Citation": "Meunier B. Hybrid molecules with a dual mode of action: Dream or reality? Acc. Chem. Res. 2008;41:69\u201377. doi: 10.1021/ar7000843.", "ArticleIdList": ["10.1021/ar7000843", "17665872"]}, {"Citation": "Panda S.S., Tran Q.L., Rajpurohit P., Pillai G.G., Thomas S.J., Bridges A.E., Capito J.E., Thangaraju M., Lokeshwar B.L. Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer. Pharmaceuticals. 2022;15:451. doi: 10.3390/ph15040451.", "ArticleIdList": ["10.3390/ph15040451", "PMC9028889", "35455448"]}, {"Citation": "Panda S.S., Girgis A.S., Thomas S.J., Capito J.E., George R.F., Salman A., El-Manawaty M.A., Samir A. Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates. Eur. J. Med. Chem. 2020;196:112293. doi: 10.1016/j.ejmech.2020.112293.", "ArticleIdList": ["10.1016/j.ejmech.2020.112293", "32311607"]}, {"Citation": "Panda S.S., Asiri A.M., Elagawany M., Buchanan D.D., Torkian B., Bathala K., Thomas S.J., Capito J.E., Arshad M.N., Al-Romaizan A.N. Efficient synthesis of pyrazinoic acid hybrid conjugates. SynOpen. 2017;1:50\u201358. doi: 10.1055/s-0036-1590800.", "ArticleIdList": ["10.1055/s-0036-1590800"]}, {"Citation": "Tangutur A.D., Kumar D., Krishna V., Kantevari S. Microtubule targeting agents as cancer chemotherapeutics: An overview of molecular hybrids as stabilizing and destabilizing agents. Curr. Top. Med. Chem. 2017;17:2523\u20132537. doi: 10.2174/1568026617666170104145640.", "ArticleIdList": ["10.2174/1568026617666170104145640", "28056738"]}, {"Citation": "Viegas-Junior C., Danuello A., da Silva Bolzani V., Barreiro E.J., Fraga C.A.M. Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes. Curr. Med. Chem. 2007;14:1829\u20131852. doi: 10.2174/092986707781058805.", "ArticleIdList": ["10.2174/092986707781058805", "17627520"]}, {"Citation": "Khwaza V., Oyedeji O.O., Aderibigbe B.A. Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update. Int. J. Mol. Sci. 2020;21:5920. doi: 10.3390/ijms21165920.", "ArticleIdList": ["10.3390/ijms21165920", "PMC7460570", "32824664"]}, {"Citation": "Thien D.D., Nguyen T.T., Thien D.G., Nguyen T.H.A., Van Sung T. Synthesis and Cytotoxic Activity of Ursolic Acid Derivatives. Z. Naturforsch. B. 2013;68:201\u2013206. doi: 10.5560/znb.2013-2261.", "ArticleIdList": ["10.5560/znb.2013-2261"]}, {"Citation": "da Silva E.F., de Vargas A.S., Willig J.B., de Oliveira C.B., Zimmer A.R., Pilger D.A., Buffon A., Gnoatto S.C.B. Synthesis and antileukemic activity of an ursolic acid derivative: A potential co-drug in combination with imatinib. Chem. Biol. Interact. 2021;344:109535. doi: 10.1016/j.cbi.2021.109535.", "ArticleIdList": ["10.1016/j.cbi.2021.109535", "34051208"]}, {"Citation": "Xu J., Wang X., Zhang H., Yue J., Sun Y., Zhang X., Zhao Y. Synthesis of triterpenoid derivatives and their anti-tumor and anti-hepatic fibrosis activities. Nat. Prod. Res. 2020;34:766\u2013772. doi: 10.1080/14786419.2018.1499642.", "ArticleIdList": ["10.1080/14786419.2018.1499642", "30445851"]}, {"Citation": "Fontana G., Bruno M., Notarbartolo M., Labbozzetta M., Poma P., Spinella A., Rosselli S. Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-\u03baB involvement. Bioorg. Chem. 2019;90:103054. doi: 10.1016/j.bioorg.2019.103054.", "ArticleIdList": ["10.1016/j.bioorg.2019.103054", "31212180"]}, {"Citation": "Ma C.-M., Cai S.-Q., Cui J.-R., Wang R.-Q., Tu P.-F., Hattori M., Daneshtalab M. The cytotoxic activity of ursolic acid derivatives. Eur. J. Med. Chem. 2005;40:582\u2013589. doi: 10.1016/j.ejmech.2005.01.001.", "ArticleIdList": ["10.1016/j.ejmech.2005.01.001", "15922841"]}, {"Citation": "Ciftci H.I., Radwan M.O., Ozturk S.E., Ulusoy N.G., Sozer E., Ellakwa D.E., Ocak Z., Can M., Ali T.F.S., Abd-Alla H., et al. Design, synthesis and biological evaluation of pentacyclic triterpene derivatives: Optimization of anti-ABL kinase activity. Molecules. 2019;24:3535. doi: 10.3390/molecules24193535.", "ArticleIdList": ["10.3390/molecules24193535", "PMC6804044", "31574910"]}, {"Citation": "Tu H.-Y., Huang A.-M., Wei B.-L., Gan K.-H., Hour T.-C., Yang S.-C., Pu Y.-S., Lin C.-N. Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species. Bioorg. Med. Chem. 2009;17:7265\u20137274. doi: 10.1016/j.bmc.2009.08.046.", "ArticleIdList": ["10.1016/j.bmc.2009.08.046", "19758808"]}, {"Citation": "Baglin I., Poumaroux A., Nour M., Tan K., Mitaine-Offer A.C., Lacaille-Dubois M.A., Chauffert B., Cave C. New Ursolic and Betulinic Derivatives as Potential Cytotoxic Agents. J. Enzym. Inhib. Med. Chem. 2003;18:111\u2013117. doi: 10.1080/1475636031000093543.", "ArticleIdList": ["10.1080/1475636031000093543", "12943194"]}, {"Citation": "Bai K.-K., Yu Z., Chen F.-L., Li F., Li W.-Y., Guo Y.-H. Synthesis and evaluation of ursolic acid derivatives as potent cytotoxic agents. Bioorg. Med. Chem. Lett. 2012;22:2488\u20132493. doi: 10.1016/j.bmcl.2012.02.009.", "ArticleIdList": ["10.1016/j.bmcl.2012.02.009", "22370266"]}, {"Citation": "Tian T., Liu X., Lee E.-S., Sun J., Feng Z., Zhao L., Zhao C. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents. Arch. Pharm. Res. 2017;40:458\u2013468. doi: 10.1007/s12272-016-0868-8.", "ArticleIdList": ["10.1007/s12272-016-0868-8", "28101738"]}, {"Citation": "Liu M.-C., Yang S.-J., Jin L.-H., Hu D.-Y., Xue W., Song B.-A., Yang S. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety. Eur. J. Med. Chem. 2012;58:128\u2013135. doi: 10.1016/j.ejmech.2012.08.048.", "ArticleIdList": ["10.1016/j.ejmech.2012.08.048", "23124210"]}, {"Citation": "Liu M.-C., Yang S.-J., Jin L.-H., Hu D.-Y., Xue W., Yang S. Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives. Med. Chem. Res. 2016;25:2267\u20132279. doi: 10.1007/s00044-016-1680-1.", "ArticleIdList": ["10.1007/s00044-016-1680-1"]}, {"Citation": "Chi K.-Q., Wei Z.-Y., Wang K.-S., Wu J., Chen W.-Q., Jin X.-J., Piao H.-R. Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1\u03b1 inhibitors with anticancer potential. Bioorg. Chem. 2017;75:157\u2013169. doi: 10.1016/j.bioorg.2017.09.013.", "ArticleIdList": ["10.1016/j.bioorg.2017.09.013", "28950243"]}, {"Citation": "Pattnaik B., Lakshmi J.K., Kavitha R., Jagadeesh B., Bhattacharjee D., Jain N., Mallavadhani U.V. Synthesis, structural studies, and cytotoxic evaluation of novel ursolic acid hybrids with capabilities to arrest breast cancer cells in mitosis. J. Asian Nat. Prod. Res. 2017;19:260\u2013271. doi: 10.1080/10286020.2016.1240169.", "ArticleIdList": ["10.1080/10286020.2016.1240169", "27762142"]}, {"Citation": "Semenova M.D., Popov S.A., Golubeva T.S., Baev D.S., Shults E.E., Turks M. Synthesis and Cytotoxicity of Sulfanyl, Sulfinyl and Sulfonyl Group Containing Ursane Conjugates with 1,3,4-Oxadiazoles and 1,2,4-Triazoles. ChemistrySelect. 2021;6:6472\u20136477. doi: 10.1002/slct.202101594.", "ArticleIdList": ["10.1002/slct.202101594"]}, {"Citation": "Khazanov V.A., Manuylova A.V., Gogvadze V., Spivak A.Y. Mitochondria-targeted betulinic and ursolic acid derivatives: Synthesis and anticancer activity. MedChemComm. 2017;8:1934\u20131945.", "ArticleIdList": ["PMC6072465", "30108714"]}, {"Citation": "Saraswat B.P., Visen K., Agarwal D.P. Ursolic acid isolated from Eucaliptus tereticornis protects against ethanol toxicity in isolated rat hepatocytes. Phytother. Res. 2000;14:163\u2013166.", "ArticleIdList": ["10815008"]}, {"Citation": "Popov S.A., Semenova M.D., Baev D.S., Frolova T.S., Shestopalov M.A., Wang C., Qi Z., Shults E.E., Turks M. Synthesis and cytotoxicity of hybrids of 1,3,4- or 1,2,5-oxadiazoles tethered from ursane and lupane core with 1,2,3-triazole. Steroids. 2020;162:108698. doi: 10.1016/j.steroids.2020.108698.", "ArticleIdList": ["10.1016/j.steroids.2020.108698", "32687846"]}, {"Citation": "Shao J.-W., Dai Y.-C., Xue J.-P., Wang J.-C., Lin F.-P., Guo Y.-H. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives. Eur. J. Med. Chem. 2011;46:2652\u20132661. doi: 10.1016/j.ejmech.2011.03.050.", "ArticleIdList": ["10.1016/j.ejmech.2011.03.050", "21514015"]}, {"Citation": "Toni C., Denner T.C., Hoenke S., Kraft O., Deigner H.-P., Al-Harrasi A., Csuk R. Hydroxyethylamide substituted triterpenoic acids hold good cytotoxicity for human tumor cells. Results Chem. 2022;4:100371."}, {"Citation": "Wiemann J., Heller L., Csuk R. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates. Bioorg. Med. Chem. Lett. 2016;26:907\u2013909. doi: 10.1016/j.bmcl.2015.12.064.", "ArticleIdList": ["10.1016/j.bmcl.2015.12.064", "26750249"]}, {"Citation": "Meng Y., Song Y., Yan Z., Xia Y. Synthesis and in vitro Cytotoxicity of Novel Ursolic Acid Derivatives. Molecules. 2010;15:4033\u20134040. doi: 10.3390/molecules15064033.", "ArticleIdList": ["10.3390/molecules15064033", "PMC6264753", "20657424"]}, {"Citation": "Bai K.-K., Chen F.-L., Yu Z., Zheng Y.-Q., Li Y.-N., Guo Y.-H. Synthesis of [3\u03b2-acetoxy-urs-12-en-28-oyl]-1-monoglyceride and investigation on its anti tumor effects against BGC-823. Bioorg. Med. Chem. 2011;19:4043\u20134050. doi: 10.1016/j.bmc.2011.05.017.", "ArticleIdList": ["10.1016/j.bmc.2011.05.017", "21664827"]}, {"Citation": "Quail D., Joyce J.A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013;19:1423\u20131437. doi: 10.1038/nm.3394.", "ArticleIdList": ["10.1038/nm.3394", "PMC3954707", "24202395"]}, {"Citation": "Kroemer G., Pouyssegur J. Tumor cell metabolism: Cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13:472\u2013482. doi: 10.1016/j.ccr.2008.05.005.", "ArticleIdList": ["10.1016/j.ccr.2008.05.005", "18538731"]}, {"Citation": "Faubert B., Solmonson A., DeBerardinis R.J. Metabolic reprogramming and cancer progression. Science. 2020;368:5473. doi: 10.1126/science.aaw5473.", "ArticleIdList": ["10.1126/science.aaw5473", "PMC7227780", "32273439"]}, {"Citation": "Pavlova N.N., Zhu J., Thompson C.B. The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022;34:355\u2013377. doi: 10.1016/j.cmet.2022.01.007.", "ArticleIdList": ["10.1016/j.cmet.2022.01.007", "PMC8891094", "35123658"]}, {"Citation": "Cassim S., Vu\u010deti\u0107 M., \u017ddralevi\u0107 M., Pouyssegur J. Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer. Cancers. 2020;12:1119. doi: 10.3390/cancers12051119.", "ArticleIdList": ["10.3390/cancers12051119", "PMC7281550", "32365833"]}, {"Citation": "Cassim S., Raymond V.A., Lacoste B., Lapierre P., Bilodeau M. Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma. Oncotarget. 2018;9:26868\u201326883. doi: 10.18632/oncotarget.25525.", "ArticleIdList": ["10.18632/oncotarget.25525", "PMC6003570", "29928490"]}, {"Citation": "Dong H., Yang X., Xie J., Xiang L., Li Y., Ou M., Chi T., Liu Z., Yu S., Gao Y., et al. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma. Biochem. Pharmacol. 2015;93:151\u2013162. doi: 10.1016/j.bcp.2014.11.014.", "ArticleIdList": ["10.1016/j.bcp.2014.11.014", "25522955"]}, {"Citation": "Yang X., Li Y., Jiang W., Ou M., Chen Y., Xu Y., Wu Q., Zheng Q., Wu F., Wang L., et al. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs. Chem. Biol. Drug Des. 2015;86:1397\u20131404. doi: 10.1111/cbdd.12608.", "ArticleIdList": ["10.1111/cbdd.12608", "26077799"]}, {"Citation": "Hua S.-X., Huang R.-Z., Ye M.-Y., Pan Y.-M., Yao G.-Y., Zhang Y., Wang H.-S. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents. Eur. J. Med. Chem. 2015;95:435\u2013452. doi: 10.1016/j.ejmech.2015.03.051.", "ArticleIdList": ["10.1016/j.ejmech.2015.03.051", "25841199"]}, {"Citation": "Friedrich S., Serbian I., Hoenke S., Wolfram R.K., Csuk R. Synthesis and cytotoxic evaluation of malachite green derived oleanolic and ursolic acid piperazineamides. Med. Chem. Res. 2020;29:926\u2013933. doi: 10.1007/s00044-020-02536-1.", "ArticleIdList": ["10.1007/s00044-020-02536-1"]}, {"Citation": "Jiang W., Huang R.-Z., Zhang J., Guo T., Zhang M.-T., Huang X.-C., Zhang B., Liao Z.-X., Sun J., Wang H.-S. Discovery of antitumor ursolic acid long-chain diamine derivatives as potent inhibitors of NF-\u03baB. Bioorg. Chem. 2018;79:265\u2013276. doi: 10.1016/j.bioorg.2018.05.005.", "ArticleIdList": ["10.1016/j.bioorg.2018.05.005", "29778798"]}, {"Citation": "Kahnt M., Fischer L., Al-Harrasi A., Csuk R. Ethylenediamine Derived Carboxamides of Betulinic and Ursolic Acid as Potential Cytotoxic Agents. Molecules. 2018;23:2558. doi: 10.3390/molecules23102558.", "ArticleIdList": ["10.3390/molecules23102558", "PMC6222718", "30297604"]}, {"Citation": "Blanchet M., Borselli D., Brunel J.M. Polyamine derivatives: A revival of an old neglected scaffold to fight resistant Gram-negative bacteria? Future Med. Chem. 2016;8:963\u2013973. doi: 10.4155/fmc-2016-0011.", "ArticleIdList": ["10.4155/fmc-2016-0011", "27227839"]}, {"Citation": "Nowotarski S.L., Woster P.M., Casero R.A. Polyamines and cancer: Implications for chemotherapy and chemoprevention. Expert Rev. Mol. Med. 2013;15:e3. doi: 10.1017/erm.2013.3.", "ArticleIdList": ["10.1017/erm.2013.3", "PMC4027058", "23432971"]}, {"Citation": "Spivak A., Khalitova R., Nedopekina D., Dzhemileva L., Yunusbaeva M., Odinokov V., D\u2019yakonov V., Dzhemilev U. Synthesis and Evaluation of Anticancer Activities of Novel C-28 Guanidine-Functionalized Triterpene Acid Derivatives. Molecules. 2018;23:3000. doi: 10.3390/molecules23113000.", "ArticleIdList": ["10.3390/molecules23113000", "PMC6278366", "30453551"]}, {"Citation": "Popov S.A., Semenova M.D., Baev D.S., Frolova T.S., Shults E.E., Wang C., Turks M. Synthesis of cytotoxic urs-12-ene- and 28-norurs-12-ene- type conjugates with amino- and mercapto-1,3,4-oxadiazoles and mercapto-1,2,4-triazoles. Steroids. 2020;153:108524. doi: 10.1016/j.steroids.2019.108524.", "ArticleIdList": ["10.1016/j.steroids.2019.108524", "31622615"]}, {"Citation": "Dheer D., Singh V., Shankar R. Medicinal attributes of 1,2,3-triazoles: Current developments. Bioorg. Chem. 2017;71:30\u201354. doi: 10.1016/j.bioorg.2017.01.010.", "ArticleIdList": ["10.1016/j.bioorg.2017.01.010", "28126288"]}, {"Citation": "Bozorov K., Zhao J., Aisa H.A. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg. Med. Chem. 2019;27:3511\u20133531. doi: 10.1016/j.bmc.2019.07.005.", "ArticleIdList": ["10.1016/j.bmc.2019.07.005", "PMC7185471", "31300317"]}, {"Citation": "Rashid S., Dar B.A., Majeed R., Hamid A., Bhat B.A. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents. Eur. J. Med. Chem. 2013;66:238\u2013245. doi: 10.1016/j.ejmech.2013.05.029.", "ArticleIdList": ["10.1016/j.ejmech.2013.05.029", "23811086"]}, {"Citation": "Meng Y.-Q., Zhang L.-F., Liu D.Y., Liu L.-W., Zhang Y., Zhao Y. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives. J. Asian Nat. Prod. Res. 2016;18:280\u2013288. doi: 10.1080/10286020.2015.1070830.", "ArticleIdList": ["10.1080/10286020.2015.1070830", "26524942"]}, {"Citation": "Meng Y.-Q., Xu C.-D., Yu T.-T., Li W., Li Q.-W., Li X.-X. Synthesis and antitumor activity evaluation of ursolic acid derivatives. J. Asian Nat. Prod. Res. 2020;22:359\u2013369. doi: 10.1080/10286020.2019.1571488.", "ArticleIdList": ["10.1080/10286020.2019.1571488", "30829054"]}, {"Citation": "Zhao C.-H., Zhang C.-L., Shi J.-J., Hou X.-Y., Feng B., Zhao L.-X. Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents. Bioorg. Med. Chem. Lett. 2015;25:4500\u20134504. doi: 10.1016/j.bmcl.2015.08.076.", "ArticleIdList": ["10.1016/j.bmcl.2015.08.076", "26343825"]}, {"Citation": "Kahnt M., Hoenke S., Fischer L., Al-Harrasi A., Csuk R. Synthesis and Cytotoxicity Evaluation of DOTA-Conjugates of Ursolic Acid. Molecules. 2019;24:2254. doi: 10.3390/molecules24122254.", "ArticleIdList": ["10.3390/molecules24122254", "PMC6630699", "31212958"]}, {"Citation": "Zhang L.-H., Zhang Z.-H., Li M.-Y., Wei Z.-Y., Jin X.-J., Piao H.-R. Synthesis and evaluation of the HIF-1\u03b1 inhibitory activities of novel ursolic acid tetrazole derivatives. Bioorg. Med. Chem. Lett. 2019;29:1440\u20131445. doi: 10.1016/j.bmcl.2019.04.028.", "ArticleIdList": ["10.1016/j.bmcl.2019.04.028", "31006525"]}, {"Citation": "Leal A.S., Wang R., Salvador J.A.R., Jing Y. Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells. Bioorg. Med. Chem. 2012;20:5774\u20135786. doi: 10.1016/j.bmc.2012.08.010.", "ArticleIdList": ["10.1016/j.bmc.2012.08.010", "22959527"]}, {"Citation": "Leal A.S., Wang R., Salvador J.A.R., Jing Y. Semisynthetic Ursolic Acid Fluorolactone Derivatives Inhibit Growth with Induction of p21waf1 and Induce Apoptosis with Upregulation of NOXA and Downregulation of c-FLIP in Cancer Cells. ChemMedChem. 2012;7:1635\u20131646. doi: 10.1002/cmdc.201200282.", "ArticleIdList": ["10.1002/cmdc.201200282", "22807348"]}, {"Citation": "Dar B.A., Lone A.M., Shah W.A., Qurishi M.A. Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents. Eur. J. Med. Chem. 2016;111:26\u201332. doi: 10.1016/j.ejmech.2016.01.026.", "ArticleIdList": ["10.1016/j.ejmech.2016.01.026", "26854375"]}, {"Citation": "Gu W., Hao Y., Zhang G., Wang S.-F., Miao T.-T., Zhang K.-P. Synthesis, in vitro antimicrobial and cytotoxic activities of new carbazole derivatives of ursolic acid. Bioorg. Med. Chem. Lett. 2015;25:554\u2013557. doi: 10.1016/j.bmcl.2014.12.021.", "ArticleIdList": ["10.1016/j.bmcl.2014.12.021", "25537271"]}, {"Citation": "Wang W.-Y., Yang Z.-H., Li A.-L., Liu Q.-S., Sun Y., Gu W. Design, synthesis, anticancer activity and mechanism studies of novel 2-amino-4-arylpyrimidine derivatives of ursolic acid. New J. Chem. 2022;46:2335\u20132350. doi: 10.1039/D1NJ05294B.", "ArticleIdList": ["10.1039/D1NJ05294B"]}, {"Citation": "Gu W., Jin X.-Y., Li D.-D., Wang S.-F., Tao X.-B., Chen H. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid. Bioorg. Med. Chem. Lett. 2017;27:4128\u20134132. doi: 10.1016/j.bmcl.2017.07.033.", "ArticleIdList": ["10.1016/j.bmcl.2017.07.033", "28733083"]}, {"Citation": "Wu J., Zhang Z.-H., Zhang L.-H., Jin X.-J., Ma J., Piao H.-R. Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1\u03b1 pathway. Bioorg. Med. Chem. Lett. 2019;29:853\u2013858. doi: 10.1016/j.bmcl.2018.12.060.", "ArticleIdList": ["10.1016/j.bmcl.2018.12.060", "30728113"]}, {"Citation": "Monteiro H.P., Costa P.E., Reis A., Stern A. Nitric Oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer. Biomed. J. 2015;38:380\u2013388.", "ArticleIdList": ["26068128"]}, {"Citation": "Ishima Y., Kragh-Hansen U., Maruyama T., Otaqiri M. Poly-S-nitrosated albumin as a safe and effective multifunctional antitumor agent: Characterization, biochemistry and possible future therapeutic applications. BioMed Res. Int. 2013;2013:353892. doi: 10.1155/2013/353892.", "ArticleIdList": ["10.1155/2013/353892", "PMC3893780", "24490156"]}, {"Citation": "Zhang T., He B., Yuan H., Feng G., Chen F., Wu A., Zhang L., Lin H., Zhuo Z., Wang T. Synthesis and antitumor evaluation in vitro of NO-donating ursolic acid-benzylidene derivatives. Chem. Biodivers. 2019;16:e1900111. doi: 10.1002/cbdv.201900111.", "ArticleIdList": ["10.1002/cbdv.201900111", "30977577"]}, {"Citation": "He B., Zhu Z., Chen F., Zhang R., Chen W., Zhang T., Wang T., Lei J. Synthesis and antitumor potential of new arylidene ursolic acid derivatives via caspase-8 activation. Arch. Pharm. 2021;354:2000448. doi: 10.1002/ardp.202000448.", "ArticleIdList": ["10.1002/ardp.202000448", "33646592"]}, {"Citation": "Wang W.-Y., Wu W.-Y., Liu Q.-S., Sun T., Gu W. Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid. Bioorg. Chem. 2021;109:104705. doi: 10.1016/j.bioorg.2021.104705.", "ArticleIdList": ["10.1016/j.bioorg.2021.104705", "33618252"]}, {"Citation": "Cui Z.L., Liu Z., Zeng J.X., Zhang S.L., Chen L., Zhang G., Xu W., Song L., Guo X. TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells. Life Sci. 2019;224:23\u201332. doi: 10.1016/j.lfs.2019.03.041.", "ArticleIdList": ["10.1016/j.lfs.2019.03.041", "30902544"]}, {"Citation": "Onmaz D.E., Abusoglu S., Unlu A., Dagli B.M., Bagci M., Tok O., Abusoglu G. Determination of serum imatinib and its\u2019 metabolite in patients chronic myeloid leukemia. Clin. Chim. Acta. 2019;497:120\u2013124. doi: 10.1016/j.cca.2019.07.025.", "ArticleIdList": ["10.1016/j.cca.2019.07.025", "31351054"]}, {"Citation": "Wang Q., Jin M., Liu Y., Sun L., Lu B., Zhao L. Synthesis, characterization and in vitro anti-proliferative effects of pentacyclic triterpenoids. Med. Chem. Res. 2021;30:2055\u20132068. doi: 10.1007/s00044-021-02795-6.", "ArticleIdList": ["10.1007/s00044-021-02795-6"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "1"}, {"Year": "2022", "Month": "12", "Day": "13"}, {"Year": "2022", "Month": "12", "Day": "14"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "50"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["36558113", "PMC9785537", "10.3390/molecules27248981", "molecules27248981"]}}], "PubmedBookArticle": []}